1. Effect of empagliflozin versus placebo on body composition in patients with acute myocardial infarction and type 2 diabetes mellitus: subgroup analysis of the EMBODY trial. (25th November 2020) Authors: Hoshika, Y; Kubota, Y; Mozawa, K; Yodogawa, K; Iwasaki, Y; Yamamoto, T; Takano, H; Tsukada, Y; Asai, K; Miyauchi, Y; Kodani, E; Maruyama, M; Tanabe, J; Shimizu, W Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗